TherapeuticsMD | TXMD - Net Income

Stock Price
2.31
Daily Change
0.02 0.76%
Monthly
2.10%
Yearly
128.46%
Q1 Forecast
2.17

TherapeuticsMD reported $-1.09M in Net Income for its fiscal quarter ending in June of 2024.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Alterity Therapeutics Limited AUD -5.77M 2.26M Jun/2023
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Grifols EUR 114.37M 34.03M Dec/2025
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pfizer USD -1.65B 5.19B Dec/2025
TherapeuticsMD USD -1.09M 356K Jun/2024